Form 4: Finch Therapeutics Director Jeffery Smisek Reports Gift Transfers of Common Stock
SEC Form 4 Filing
Director Jeffery Smisek reports gifting of Finch Therapeutics Group, Inc. common stock, both directly and indirectly through his spouse.
Summary
- On June 7, 2024, Jeffery A Smisek, a director of Finch Therapeutics Group, Inc., reported changes in his beneficial ownership of the company's common stock.
- Smisek gifted 384 shares of common stock directly.
- Smisek's spouse gifted 383 shares of common stock.
- Following these transactions, Smisek directly owns 17,870 shares and indirectly owns 24,383 shares through his spouse.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock gifts, which carries a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in ownership but doesn't necessarily reflect a change in the company's overall financial health or strategic direction.
Stakeholder Impact
- The stock gifts may have a minor impact on shareholders due to the change in ownership percentages, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of stock gift transactions. |
| 06/10/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Finch Therapeutics, Smisek, Stock Gift, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.